Dhaval K Shah

32PUBLICATIONS
17CO-AUTHORS
NanomedicineMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 29, 2026
Whole-Body Pharmacokinetics of Ionizable Lipid, mRNA, and the Expressed Antibody following Intravenous Administration of mRNA-Loaded Lipid Nanoparticles.

|Apr 27, 2026
The Effect of FcRn Binding on Ocular Disposition of Monoclonal Antibodies.

|Apr 02, 2026
Whole-Body Pharmacokinetics of Lipid, mRNA and Translated Protein Following Intravenous Administration of Spike Protein Expressing mRNA-LNP in Mice.

Mokshada Kumar, Shrusti Tiwari, Aneesh Rajwade

|Jan 28, 2026
Oral Bioavailability of Monoclonal Antibody.

Ashwni Verma, Shengjia Wu, Dhaval K Shah

|Jan 06, 2026
Investigation of Monoclonal Antibody Pharmacokinetics in Pediatric Population and Characterization Using a Platform PBPK Model.

Mokshada Kumar, Sravani Lanke, Dhaval K Shah

|Apr 23, 2025
Effect of Acute Lung Injury (ALI) Induced by Lipopolysaccharide (LPS) on the Pulmonary Pharmacokinetics of an Antibody.

Shweta Jogi, Dhaval K Shah

Pageof 6

Frequent Collaborators

3 joint publications

Ashwni Verma

3 joint publications

Hsuan-Ping Chang

2 joint publications

Hsueh-Yuan Chang

2 joint publications

Shrusti Tiwari